Re : Nivolumab in Combination with Stereotactic Body Radiotherapy in Pretreated Patients with Metastatic Renal Cell Carcinoma. Results of the Phase II NIVES Study
| Errataetall: |
CommentOn: Eur Urol. 2022 Mar;81(3):274-282. - PMID 34602312 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:81 |
|---|---|
| Enthalten in: |
European urology - 81(2022), 2 vom: 15. Feb., Seite 216 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Spaas, Mathieu [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
31YO63LBSN |
|---|
| Anmerkungen: |
Date Completed 18.04.2022 Date Revised 18.04.2022 published: Print-Electronic CommentOn: Eur Urol. 2022 Mar;81(3):274-282. - PMID 34602312 Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.eururo.2021.11.003 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM333473248 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM333473248 | ||
| 003 | DE-627 | ||
| 005 | 20231225221726.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.eururo.2021.11.003 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1111.xml |
| 035 | |a (DE-627)NLM333473248 | ||
| 035 | |a (NLM)34810013 | ||
| 035 | |a (PII)S0302-2838(21)02145-X | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Spaas, Mathieu |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Re |b Nivolumab in Combination with Stereotactic Body Radiotherapy in Pretreated Patients with Metastatic Renal Cell Carcinoma. Results of the Phase II NIVES Study |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 18.04.2022 | ||
| 500 | |a Date Revised 18.04.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a CommentOn: Eur Urol. 2022 Mar;81(3):274-282. - PMID 34602312 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Comment | |
| 650 | 7 | |a Antineoplastic Agents, Immunological |2 NLM | |
| 650 | 7 | |a Nivolumab |2 NLM | |
| 650 | 7 | |a 31YO63LBSN |2 NLM | |
| 700 | 1 | |a Sundahl, Nora |e verfasserin |4 aut | |
| 700 | 1 | |a Ost, Piet |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t European urology |d 1977 |g 81(2022), 2 vom: 15. Feb., Seite 216 |w (DE-627)NLM000137588 |x 1873-7560 |7 nnns |
| 773 | 1 | 8 | |g volume:81 |g year:2022 |g number:2 |g day:15 |g month:02 |g pages:216 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.eururo.2021.11.003 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 81 |j 2022 |e 2 |b 15 |c 02 |h 216 | ||